* Laboratory Corporation of America Holdings LH.N LH is
expected to show a fall in quarterly revenue when it reports
results on April 25.
* The Burlington North Carolina-based company is expected
to
report a 5.3% decrease in revenue to $3.692 billion from $3.9
billion a year ago, according to the mean estimate from 11
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Laboratory
Corporation of
America Holdings is for earnings of $3.96 per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 13 "strong buy" or "buy," 4
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts had fallen by
about 0.6%
in the last three months.
* Wall Street's median 12-month price target for Laboratory
Corporation of America Holdings is $288, above its last
closing price of $231.54.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Dec. 31 2022 4.08 4.10 4.14 Beat 0.9
Sep. 30 2022 4.67 4.67 4.68 Beat 0.3
Jun. 30 2022 4.73 4.70 4.95 Beat 5.3
Mar. 31 2022 6.07 5.98 6.11 Beat 2.2
Dec. 6.27 5.80 6.77 Beat 16.8
31 2021
Sep. 30 2021 5.17 4.92 6.82 Beat 38.7
Jun. 30 2021 5.56 5.53 6.13 Beat 10.9
Mar. 31 2021 7.47 7.43 8.79 Beat 18.3
This summary was machine generated April 21 at 15:02 GMT. All
figures in US dollars unless otherwise stated